A trip to Edinburgh for #12thScottishBladderCancerSymposium It's #bladdercancer month & we must remember that bladder cancer outcomes must improve @alisonbirtle.bsky.social
@alisonbirtle.bsky.social
Gu oncologist. Patient advocate. Researcher.musical theatre enthusiast .
🚨May is Bladder Cancer awareness month🚨 What better way to mark this than a Simply Oncology Bladder Cancer episode with the irrepressible @alisonbirtle.bsky.social 🎙️We discuss peri-operative treatment & NIAGARA trial #BladderCancer @tapiajc.bsky.social @achoud72.bsky.social @abcuk.bsky.social
7years ago. No 1 abstract GU Asco Sam Francisco. Changing practice . Thanks to all the 75 uk centres who contributed at least one patient , the trials teams and all the families and patients especially Andrew Winterbottom amd Chris Davies ,lay members on trial group
🚦First episode of 2025 Simply Oncology podcast out Friday with the ever excellent Alison Birtle🎙️ We covered ‘The Triple Question in mHSPC in the last episode 🎯 🎙️This time we cover all things metastatic castrate resistant prostate cancer🎙️ @alisonbirtle.bsky.social @simplyoncology.bsky.social
Trying to find the gif I want is.challenging. this one has the right pic but the words are a bit blurred. So Happy Christmas all and thank you for being a positive force
a christmas card with a nativity scene and the words merry christmas
ALT: a christmas card with a nativity scene and the words merry christmas
media.tenor.com
#NHS #nhsEngland #Cancer Pls like and share go.bsky.app/2mwnYaX
Systematic review of radiosensitisation with bladder preserving radiotherapy. ➡️ Use a radiosensitiser wherever possible, doesn't matter which one ➡️ Highest level of evidence for #BCON & #5FUMMC 👏🏽👏🏽👏🏽👇🏽 www.sciencedirect.com/science/arti...
Concomitant Chemotherapy in Trimodal Treatment of Patients with Muscle Invasive Bladder Cancer: A Systematic Review of Prospective Trials
For selected patients with muscle-invasive bladder cancer (MIBC), trimodal therapy (TMT) incorporating transurethral resection of the tumor and chemor…
sciencedirect.com
Post hoc analysis of TITAN in metastatic castration sensitive #ProstateCancer
The OncoAlert Network 🚨@oncoalert.bsky.social · 2y agoPost hoc analysis of TITAN examined the association between achieving ultralow prostate-specific antigen (PSA) levels (≤0.2 ng/mL) and clinical outcomes in patients with metastatic castration-sensitive #ProstateCancer (mCSPC) treated with apalutamide. https://buff.ly/3CJA5bO
Well I've joined a few starters packs, and followed a few more. Feeling somewhat clueless. So here's a throw back pic to #EMUC 2018 presenting the POUT trial data.
